首页> 外文期刊>Journal of drug targeting >Recent advances in metal nanoparticles in cancer therapy
【24h】

Recent advances in metal nanoparticles in cancer therapy

机译:癌症治疗中金属纳米粒子的最新进展

获取原文
获取原文并翻译 | 示例
           

摘要

Metal nanoparticles (NPs) may have the potential to overcome problems related to conventional chemotherapy. Metal NPs reported to play a beneficial and powerful role in cancer therapy providing better targeting, gene silencing and drug delivery. Functionalised metal NPs with targeting ligands offer a better control of energy deposition in the tumours. Apart from therapeutic benefits, metal NPs are also used as a diagnostic tool for the imaging of cancer cells. Metal NP-based therapeutic systems not only provide simultaneous diagnostic and therapy but also allow controlled and targeted drug release which helps to revolutionise cancer treatment and management. This review addresses the advancement of metal NPs in tumour therapy with a focus on those being explained into clinical settings. ? 2017, ? 2017 Informa UK Limited, trading as Taylor & Francis Group.
机译:金属纳米颗粒(NPS)可能有可能克服与常规化疗相关的问题。 据报道,金属NPS在癌症治疗中发挥有益和强大的作用,提供更好的靶向,基因沉默和药物递送。 官能化金属NPS具有靶向配体,可以更好地控制肿瘤中的能量沉积。 除了治疗益处,金属NPS还用作癌细胞成像的诊断工具。 基于金属NP的治疗系统不仅提供同时诊断和治疗,还允许受控和靶向药物释放,这有助于彻底改变癌症治疗和管理。 该审查涉及金属NPS在肿瘤疗法中的进步,重点关注那些被解释为临床环境的人。 还 2017年,? 2017年Informa UK Limited,贸易为泰勒&弗朗西斯集团。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号